|
The impact of social determinants of health (SDOH) on use of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting. |
|
|
|
Consulting or Advisory Role - Myriad Genetics |
(OPTIONAL) Uncompensated Relationships - Clovis Oncology |
|
|
Employment - Amgen; Ontada/McKesson |
Stock and Other Ownership Interests - Amgen |
Research Funding - Gilead Sciences (I) |
|
|
Employment - Ontada/McKesson |
|
|
|
Stock and Other Ownership Interests - McKesson |
|
|
|
Consulting or Advisory Role - Immunomedics; Novartis; Pfizer; Seagen |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Pfizer; Seagen |
Speakers' Bureau - AstraZeneca; daiichsankyo; Gilead Sciences; Immunomedics; Merck; Stemline Therapeutics |
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Merck; Pfizer; Stemline Therapeutics |
|
|
Travel, Accommodations, Expenses - McKesson |
(OPTIONAL) Uncompensated Relationships - Center for Genomic Interpretation |
|
|
No Relationships to Disclose |
|
|
Employment - Compass Oncology; McKesson |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Pfizer (Inst) |
|
|
|
|
Stock and Other Ownership Interests - McKesson; Moderna Therapeutics; Oncolytics (I) |
Honoraria - Bristol-Myers Squibb; Roche |
Consulting or Advisory Role - Advi; Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health |